Concurrent chemoradiotherapy using carboplatin/cetuximab regimen in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) not eligible for high-dose cisplatin (HD-DDP)

被引:0
|
作者
Saigal, Kunal
Warsch, Sean
Mandalia, Amar
Samuels, Michael
Tolba, Khaled A.
Ikpeazu, Chukwuemeka
Kwon, Deukwoo
Santos, Edgardo S.
机构
[1] Univ Miami, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16001
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Weekly Paclitaxel and Carboplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Ready, Neal E.
    Rathore, Ritesh
    Johnson, Tirrell T.
    Nadeem, Ahmed
    Chougule, Prakash
    Ruhl, Charles
    Radie-Keane, Kathy
    Theall, Kathy
    Wanebo, Harold J.
    Marcello, Jennifer
    Kennedy, Teresa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01): : 6 - 12
  • [42] Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results from an EORTC led survey
    Oosting, S.
    Desideri, I.
    Staelens, D.
    Caballero, C.
    Tribius, S.
    Simon, C.
    Singer, S.
    Gregoire, V.
    Fortpied, C.
    Luciani, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 393 - 393
  • [43] Cisplatin Versus Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
    Nassif, Sandy
    Wichmann, Jorn
    Strube, Dominic
    Vassis, Stratos
    Christiansen, Hans
    Steinmann, Diana
    IN VIVO, 2022, 36 (02): : 821 - 832
  • [44] Outcomes of concurrent radiation with cisplatin versus cetuximab in locally-advanced head and neck squamous cell carcinoma (LAHNSCC).
    Ly Viet Do
    Dowlatshahi, Morteza
    Parekh, Zayd
    Trevino, Richard
    Eng, Richard
    Fann, Karen
    Dinh, Ngon
    Lee, Raymond W.
    Lee, Charlene Sen-Yee
    Hla, Tin T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
    Rui-Xue Huo
    Ying-Ying Jin
    Yong-Xue Zhuo
    Xiao-Tong Ji
    Yu Cui
    Xiao-Jing Wu
    Yi-Jia Wang
    Long Zhang
    Wen-Hua Zhang
    Yu-Mei Cai
    Cheng-Cheng Zheng
    Rui-Xue Cui
    Qian-Ye Wang
    Zhen Sun
    Feng-Wei Wang
    World Journal of Clinical Cases, 2022, 10 (11) : 3414 - 3425
  • [46] Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
    Huo, Rui-Xue
    Jin, Ying-Ying
    Zhuo, Yong-Xue
    Ji, Xiao-Tong
    Cui, Yu
    Wu, Xiao-Jing
    Wang, Yi-Jia
    Zhang, Long
    Zhang, Wen-Hua
    Cai, Yu-Mei
    Zheng, Cheng-Cheng
    Cui, Rui-Xue
    Wang, Qian-Ye
    Sun, Zhen
    Wang, Feng-Wei
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (11) : 3414 - 3425
  • [47] A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Enokida, Tomohiro
    Ogawa, Takenori
    Homma, Akihiro
    Okami, Kenji
    Minami, Shujiro
    Nakanome, Ayako
    Shimizu, Yasushi
    Maki, Daisuke
    Ueda, Yuri
    Fujisawa, Takao
    Motegi, Atsushi
    Ohkoshi, Akira
    Taguchi, Jun
    Ebisumoto, Koji
    Nomura, Shogo
    Okano, Susumu
    Tahara, Makoto
    CANCER MEDICINE, 2020, 9 (05): : 1671 - 1682
  • [48] Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis
    Mohamed, Amr
    Twardy, Brandon
    Zordok, Magdi A.
    Ashraf, Khuram
    Alkhoder, Ayman
    Schrapp, Kelly
    Steuer, Conor
    Chen, Zhengjia
    Pakkala, Suchita
    Pillai, Rathi
    Wadsworth, J. Trad
    Higgins, Kristin
    Beitler, Jonathan J.
    Ramalingam, Suresh S.
    Owonikoko, Taofeek K.
    Khuri, Fadlo R.
    Shin, Dong M.
    Behera, Madhusmita
    Saba, Nabil F.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (05): : 1490 - 1498
  • [49] Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A randomized controlled multi-centered trial
    He, X.
    Yin, H.
    Guo, W.
    Sun, X.
    Hu, X.
    Yan, P.
    Li, F.
    Huang, S.
    Zhou, H.
    Zhang, F.
    Wang, B.
    Bian, X.
    Wei, Q.
    Wu, J.
    Wang, F.
    Song, D.
    Liu, J.
    Zhou, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Renal Outcomes in High-Dose Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A New and Interesting Perspective
    Trevisani, Francesco
    Quattrini, Giulia
    Pugno, Daniele
    Pegoraro, Giulia
    Cinque, Alessandra
    Gregorc, Vanesa
    Mirabile, Aurora
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 578 - 578